Terms: = Brain cancer AND PRCC, Q92733, TPRC, RCCP1, MGC4723, MGC17178, ENSG00000143294, 5546 AND Diagnosis
3 results:
1. Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival.
Dudani S; de Velasco G; Wells JC; Gan CL; Donskov F; Porta C; Fraccon A; Pasini F; Lee JL; Hansen A; Bjarnason GA; Beuselinck B; Pal SK; Yuasa T; Kroeger N; Kanesvaran R; Reaume MN; Canil C; Choueiri TK; Heng DYC
JAMA Netw Open; 2021 Jan; 4(1):e2021869. PubMed ID: 33475752
[TBL] [Abstract] [Full Text] [Related]
2. Multilayered molecular profiling supported the monoclonal origin of metastatic renal cell carcinoma.
Huang Y; Gao S; Wu S; Song P; Sun X; Hu X; Zhang S; Yu Y; Zhu J; Li C; Qin Z; Xie L; Yao Q; Tang A; Li Z; Guo G; Wan S; Dong P; Sun L; Li W; Wang D; Gui Y; Yang H; Zhou F; Zhang X; Cai Z
Int J Cancer; 2014 Jul; 135(1):78-87. PubMed ID: 24310851
[TBL] [Abstract] [Full Text] [Related]
3. A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor.
Mai KT; Landry DC; Robertson SJ; Commons AS; Burns BF; Thijssen A; Collins J
Pathol Res Pract; 2001; 197(10):671-5. PubMed ID: 11700888
[TBL] [Abstract] [Full Text] [Related]
